Pages that link to "Q33536757"
Jump to navigation
Jump to search
The following pages link to Molecular genetics and epidemiology of prostate carcinoma. (Q33536757):
Displaying 42 items.
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (Q24654019) (← links)
- Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance (Q24682963) (← links)
- Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina (Q24811531) (← links)
- Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma (Q28360358) (← links)
- The role of vitamin D in prostate cancer (Q31943361) (← links)
- A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth. (Q33955634) (← links)
- Viruses in the mammalian male genital tract and their effects on the reproductive system (Q34010343) (← links)
- Vitamin D metabolism and action in the prostate: Implications for health and disease (Q34027269) (← links)
- Interrogating genomic and epigenomic data to understand prostate cancer (Q34125866) (← links)
- A review of genetic polymorphisms and prostate cancer risk (Q34565351) (← links)
- Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice (Q34928897) (← links)
- Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. (Q35082189) (← links)
- Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer (Q35097143) (← links)
- Pharmacogenomic considerations in drug delivery (Q35164676) (← links)
- Dysregulation of the annexin family protein family is associated with prostate cancer progression (Q35748826) (← links)
- Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer (Q35759762) (← links)
- Genomic and epigenomic alterations in prostate cancer. (Q36374578) (← links)
- Targeting of EGFR tyrosine kinase by ZD1839 ("Iressa") in androgen-responsive prostate cancer in vitro (Q36400144) (← links)
- A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer (Q36403691) (← links)
- Progress in gene therapy for prostate cancer (Q36406911) (← links)
- hTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer (Q36913437) (← links)
- Inhibition of hedgehog and androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progression (Q37325266) (← links)
- Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor (Q38078285) (← links)
- Differential action of glycoprotein hormones: significance in cancer progression (Q38152983) (← links)
- Prostate-specific antigen: any successor in sight? (Q38162201) (← links)
- Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer (Q38774692) (← links)
- How can food extracts consumed in the Mediterranean and East Asia suppress prostate cancer proliferation? (Q39446343) (← links)
- A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer (Q39709581) (← links)
- Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor (Q40399499) (← links)
- Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation (Q42148183) (← links)
- Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity (Q43114709) (← links)
- Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients (Q43736737) (← links)
- Partial enzymatic elimination and quantification of sarcosine from alanine using liquid chromatography-tandem mass spectrometry (Q43816801) (← links)
- Phosphotyrosine phosphatase SHP-1, somatostatin and prostate cancer (Q44973981) (← links)
- Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers (Q46301105) (← links)
- A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers. (Q47825566) (← links)
- Dynamic rewiring of the androgen receptor protein interaction network correlates with prostate cancer clinical outcomes. (Q53282043) (← links)
- Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy! (Q64990590) (← links)
- Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells (Q73530529) (← links)
- Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men (Q77223275) (← links)
- A preliminary study on the possible role for luteinizing hormone in androgen independent growth of prostate (Q78752467) (← links)
- Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial (Q92286873) (← links)